2. Wang YG, Zhao LY, Liu CQ, et al. 2016; Clinical characteristics and prognostic factors of primary gastric lymphoma: A retrospective study with 165 cases. Medicine (Baltimore). 95:e4250. DOI:
10.1097/MD.0000000000004250. PMID:
27495029. PMCID:
PMC4979783.
4. Park HS, Kim YJ, Yang WI, Suh CO, Lee YC. 2010; Treatment outcome of localized Helicobacter pylori-negative low-grade gastric MALT lymphoma. World J Gastroenterol. 16:2158–2562. DOI:
10.3748/wjg.v16.i17.2158. PMID:
20440857. PMCID:
PMC2864842.
Article
5. Zullo A, Hassan C, Cristofari F, et al. 2010; Effects of Helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma. Clin Gastroenterol Hepatol. 8:105–110. DOI:
10.1016/j.cgh.2009.07.017. PMID:
19631287.
Article
7. Malfertheiner P, Megraud F, O'Morain C, et al. 2007; Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 56:772–781. DOI:
10.1136/gut.2006.101634. PMID:
17170018. PMCID:
PMC1954853.
Article
9. Moleiro J, Ferreira S, Lage P, Dias Pereira A. 2016; Gastric malt lymphoma: Analysis of a series of consecutive patients over 20 years. United European Gastroenterol J. 4:395–402. DOI:
10.1177/2050640615612934. PMID:
27403306. PMCID:
PMC4924435.
Article